TUBB1 Q43P polymorphism does not protect against acute coronary syndrome and premature myocardial infarction

Thrombosis and Haemostasis

Volumn 100, Issue 6, 2008, Pages 1211-1213

  Navarro Núñez, Leyre ^a   Roldán, Vanessa ^a   Lozano, María Luisa ^a   Rivera, José ^a   Marin, Francisco ^b   Vicente, Vicente ^a   Martínez, Constantino ^a,c  

^a UNIVERSITY OF MURCIA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^c HOSPITAL UNIVERSITARIO MORALES MESEGUER   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 1 TUBULIN; BETA TUBULIN; GENOMIC DNA; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; ADULT; AGED; ALLELE; ARTERY THROMBOSIS; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL FEATURE; DNA ISOLATION; FEMALE; GENE AMPLIFICATION; GENE INTERACTION; GENETIC POLYMORPHISM; GENOTYPE; HEART INFARCTION; HEART PROTECTION; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN FUNCTION;

ACUTE CORONARY SYNDROME; ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; BLOOD PLATELETS; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; SPAIN; TUBULIN;

EID: 57349148120     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH08-05-0329     Document Type: Letter

References (12)

1. Atherosclerosis, Thrombosis, and Vascular Biology Italian Study Group. No evidence of association between prothrombotic gene polymorphisms and the development of acute myocardial infarction at young age. Circulation 2003; 107: 1117-1122.
2. Shiffman D, O'Meara ES, Bare LA, et al. Association of Gene Variants With Incident Myocardial In farction in the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 2008; 28: 173-179.
3. Jackson SP, Schoenwaelder SM. Antiplatelet therapy: in search of the 'magic bullet'. Nat Rev Drug Discov 2003; 2: 775-789.
4. Freson K, De Vos R, Wittevrongel C, et al. The TUBB1 Q43P functional polymorphism reduces the risk of cardiovascular disease in men by modulating platelet function and structure. Blood 2005; 106: 2356-2362.
5. Navarro-Nuñez L, Lozano ML, Rivera J, et al.The association of the β1-tubulin Q43P polymorphism with intracerebral hemorrhage in men. Haematologica 2007; 92: 513-518.
6. Roldán V, Corral J, Marín F, et al. Synergistic association between hypercholesterolemia and the C46T factor XII polymorphism for developing premature myocardial infarction. Thromb Haemost 2005; 94: 1294-1299.
7. Tello-Montoliu A, Marín F, Patel J, et al. plasma angiogenin levels in acute coronary syndromes: implication for prognosis. Eur Heart J 2007; 28: 3006-3011.
8. Miñano A, Ordóñez A, España F, et al. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms. Haematologica 2008; 93: 729-734.
9. Ye Z, Liu EH, Higgins JP, et al. Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66,155 cases and 91,307 controls. Lancet 2006; 367: 651-658.
10. Roldan V, Gonzalez-Conejero R, Marin F, et al. Five prothrombotic polymorphisms and the prevalence of premature myocardial infarction. Haematologica 2005; 90: 421-423.
11. Pernod G, Ormezzano O, Vanzetto G. Gene-gene interactions in myocardial infarction. Lancet 2006; 367: 1729-1730.
12. Vokó Z, Bereczky Z, Katona E, et al. Factor XIII Val34Leu variant protects against coronary artery disease. A meta-analysis. Thromb Haemost 2007; 97: 458-463.